top of page

Product Pipeline

Ver2_edited.jpg

Product Pipeline - Human

IRP has completed the screening of four drug-resistant bacteria and their combinations, including Clostridium difficile, Campylobacter, ESBL + resistant bacteria, and Staphylococcus aureus.

IRP004CD

IRP004CB

Human being

Clostridium difficile

Pseudomembranous enteritis is an acute mucosal necrotic inflammation that mainly occurs in the colon and is covered with a pseudomembrane. It has been confirmed to be caused by the toxin of Clostridium difficile. Severe illness can be fatal. It has been listed as a serious threat by the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO).

Human being

Campylobacter

Campylobacter is one of the four global causes of diarrhea. The bacterium is the most common cause of gastroenteritis from a bacterial perspective in the world. Campylobacter infections are usually mild, but can be fatal to very young children, the elderly, and immunosuppressed people.

Phermatix

Human being

Extended Spectrum
Beta-Lactamases

Because of its resistance to major antibiotics, there are fewer types of antibiotics currently available. ESBL + drug-resistant bacteria cause serious harm to human beings. The World Health Organization (WHO) and the US Centers for Disease Surveillance and Prevention (CDC) have classified ESBL + drug-resistant bacteria as ‘emergency’.

IRP004SA

Human being

Staphylococcus aureus

It is an important pathogenic bacteria in humans and a representative of Gram-negative bacteria, which can cause many serious infections. The United States Centers for Disease Control (CDC) reports that infections caused by Staphylococcus aureus account for the second place, only for E. coli.

Prof. Dena Lyras

Prof. Jian Li

Prof. Jian Li

Prof. Jian Li ;

Dr. Darren Trott

Product

Target Species

Diseases

Incidence

Collaborator

* List of commonly used antibacterial products for human use

Me much better Related product development process and progress

Drug Name

Indications

Potential market
size
(by 2030)

IP

R&D process and current progress

Target

Compound

Experimental
Verification

Formulation

Small Batch
Production

TGA
Filing

Market

Mass
Production

Australian
Market

FDA
Filing

American
market

Chinese market

Drug
declarations

Cross-border
e-commerce sales

Note

UPPLUS-A
Capsule

Respiratory
health

$26.5 billion

Acquired

UPPLUS
KBD Spray

Respiratory
health

$26.5 billion

Acquired

Australian Market and Cross-border e-commerce sales in the Chinese market have been carried out. The U.S. market is already legally accessible, and China's long-term market is yet to be developed.

UPPLUS-G

Brain health

$230.1 billion

Available

UPPLUS-B

Weight

Control

$825 billion

Available

UPPLUS-F

Enhancing
Immunity for
against cancers

$581.25 billion

Available

UPPLUS-N

Insomnia

$1.87 billion

Available

UPPLUS-E

Osteoporosis

$22,947 million

Available

UPPLUS-L

CVD and
hypercholester
olemia

$34 billion

Available

UPPLUS-T

UPPLUS-BC

Anti-ageing

$119.6 billion

Available

Breast
Cancer

$47.7 billion

Available

UPPLUS-LC

Lung Cancer

$48 billion

Available

UPPLUS-CC

Colorectal
Cancer

$39.83 billion

Available

UPPLUS-PC

Prostate
Cancer

$30 billion

Available

UPPLUS-SC

Skin Cancer
(Melanoma)

$16.94 billion

Available

Untitled design.png

Product Pipeline - Animal

Gut-C: Feed Additive for Chicken

Gut-C, in the form of feed additive premix, can inhibit Coccidiosis, prevent/treat Necrotic Enteritis, reduce the amount of Campylobacter, and enhance FCR.

Product

Target Species

Diseases

Incidence

Collaborator

Prof. Chuck;

Prof. Rob.Moore

Prof.Chuck;
Prof.Pat Blackall

Prof. Peter Grover;
Greg.

Gut-C

Chicken

Necrotic Enteritis

Chicken

Campylobacteriosis

Chicken

Coccidiosis

Necrotic Enteritis (NE) is an intestinal gut infection found in food-producing animals such as poultry.

Campylobacteriosis is a gastrointestinal disease. It can spread widely through contact. EU and the US have highlighted the plight of CB in chicken and called for control before processing.

Coccidiosis is caused by parasite Eimeria. It can reduce FCR by affecting weight gain. 95.61% of economic loss in broiler industry is attributed to this diseases.

Gut-P: Feed Additive for Pigs

Gut-P can prevent and treat Ileitis in pigs caused by Lawsonia.

Product

Target Species

Diseases

Incidence

Collaborator

Gut-P

Pig

Lawsonia

Ileitis is the No.1 health problem in growing pigs. Nearly 42% of grow/finish operations reported clinical ileitis and nearly 94% of herds found to have subclinical ileitis. The mortality rate can be as high as 50%.

Dr. Ryan Saltzman

Gut-X: Veterinary medicine for cattle

Gut-X is used to treat cattle mastitis.

Product

Target Species

Diseases

Incidence

Collaborator

Gut-X

Cattle

Mastitis

Mastitis is the inflammation of the mammary gland and udder tissue, and is a major endemic disease of dairy cattle. It usually occurs as an immune response to bacterial invasion of the teat canal by variety of bacterial sources present on the farm, and can also occur because of chemical, mechanical, or thermal injury to the cow's udder.

Dr. Darren Troot

Product Pipeline - mRNA Vaccine for Animal Use

Product

Target Species

Diseases

Incidence

Collaborator

ASF

Porcine
circovirus

Porcine
Parvovirus

Pig

Pig

Pig

Bovine viral
diarrhea

Cattle

Canine core
vaccines

Dog

Non-core
vaccines

Dog/Cat

African swine fever

Has been around for about a century, bringing huge losses and threats to the world's pig industry.

Prof. Colin Pouton

Porcine circovirus

One of the three major diseases that have been plaguing pig industry in China.

Porcine Parvovirus

Mainly manifested in the infection and death of embryos and fetuses, especially the stillbirth, malformation and mummified fetuses of first-born sows, but the sows themselves have no obvious symptoms.

Bovine viral diarrhea

One of the major cattle diseases worldwide. Like other viral diseases, BVD cannot be treated.

CDV,CAV,CPV-2

CDV,CAV,CPV-2

Leptospirosis

Is a zoonotic disease in the tropics and subtropics. China is one of the countries most affected by leptospirosis, and also the country with the most abundant leptospirosis serotypes in the world.

123 Whitehorse Rd

Balwyn VIC 3103, Australia

© 2024 by IRP Health.

​

Disclaimer: This website's information is for general purposes only. Statements related to potential therapeutic benefits or product development should not be interpreted as medical recommendations. We encourage visitors to consult with healthcare professionals for personalized advice.

bottom of page